RecruitingNCT07512518

Observational Cohort Study of Chronic Viral Infection in the Central Nervous System

Central Nervous System Chronic Viral Infections: A Cohort Study


Sponsor

Peking Union Medical College Hospital

Enrollment

66 participants

Start Date

Feb 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This research team intends to conduct a real-world cohort study of chronic CNS viral infections represented by PML, to evaluate whether administration of immune checkpoint inhibitors improves long-term outcomes in this patient population.Patients with prior follow-up will be enrolled into a retrospective/prospective ambidirectional cohort, and newly diagnosed patients will be enrolled into a prospective cohort.


Eligibility

Min Age: 14 Years

Inclusion Criteria5

  • Age > 14 years old.
  • Confirmed diagnosis of chronic viral infection of the central nervous system (CNS).
  • Signed informed consent. The diagnosis of Progressive Multifocal Leukoencephalopathy (PML) shall meet one of the following criteria:(1) Neuropathological diagnosis: Pathological examination of brain tissue shows demyelination, bizarre astrocytes, and enlarged oligodendroglial nuclei; immunohistochemical detection of JC virus (JCV) antigen.(2) Clinical + imaging + cerebrospinal fluid (CSF) diagnosis: Clinical manifestations of progressive neurological dysfunction; neuroimaging shows single or multiple asymmetric white matter lesions with large volume, mostly involving the U-fibers, and rare mass effect; detection of JC virus DNA in cerebrospinal fluid. Specific reference shall be made to the 2013 American Academy of Neurology (AAN) diagnostic criteria.
  • For the diagnosis of other chronic viral infections of the central nervous system, the clinical manifestations shall be consistent with the characteristics of the relevant diseases, and the relevant viral DNA shall be detected in the cerebrospinal fluid.
  • The diagnosis of all cases must be independently confirmed by two physicians from the Encephalitis Professional Group, Department of Neurology, Peking Union Medical College Hospital, with consistent diagnostic results, to be included in the study. For cases with inconsistent diagnoses, the two physicians shall conduct consultations to reach a consensus. Patients with unreached diagnostic consensus shall not be included in the study.

Exclusion Criteria3

  • Presence of lumbar puncture contraindications, making it impossible to collect cerebrospinal fluid.
  • The attending physician and the researcher consider that the detection of virus in cerebrospinal fluid cannot explain the patient's clinical manifestations.
  • Inability to complete 1-year follow-up.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGImmune Checkpoint Inhibitors

Immune Checkpoint Inhibitors for PML treatment


Locations(1)

Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07512518


Related Trials